bioAffinity Technologies, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
bioAffinity Technologies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2024.
  • bioAffinity Technologies, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$17.1K, a 140% decline year-over-year.
  • bioAffinity Technologies, Inc. annual Nonoperating Income (Expense) for 2023 was $57.2K.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$17.1K -$59.8K -140% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$12.9K -$49.9K -135% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $42.8K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $37K +$1.18M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$1.15M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.